ration was made from uninfected cells treated in parallel.
Ninety-six-well NUNC plates were coated with 2.5 g antigen! well/0.l ml of PBS, saturated with 1% BSA and successively incubated with sera diluted 1/100 in PBS containing 0.1%
Tween 20 (PBS-T), peroxidase-labeled sheep anti-human IgG (Diagnostics Pasteur) and substrate (OPD). Each incubation step was followed by washes in PBS-T. Results are expressed as delta OD (average OD of two wells coated with infected cell antigen-average OD of two wells coated with uninfected cell antigen). A delta OD of 0.2 was considered negative.
Detection of CMV genome by PCR amplification Processing of samples. Renal biopsy fragments were ground mechanically and incubated for 48 hours at 37°C in 500 p1 of lysis buffer (0.1 M Tris, pH 7.4, 0.01 M EDTA, 0.5% SDS) containing 200 g/ml of Proteinase K (Merck). Samples were then extracted twice with a phenol (vol/vol 50%)-chloroform (48%)-isoamyl alcohol (2%) mixture. DNA was precipitated with ethanol and resuspended in 20 .d of distilled water.
Amplification procedure. The primers used for specific amplification of CMV DNA (A, 5'-GGA TCC GCA TGG CAT TAC CGT ATG T-3' and D, 5'-GAA TTC AGT GGA TAA CCT GCG GCG A-3') were synthesized (Laboratoire de Chimie Organique, Institut Pasteur, France) based on sequence data of Weston and Barrell [16] . They frame a 406 bp region within the HindIII-X fragment of the Ad-169 CMV strain which region was found to be highly conserved in 60 fresh human isolates of CMV examined (unpublished results and Fig. 1 ). Each DNA specimen was amplified for 30 cycles using a Hybaid apparatus (Cera Labo) in two independent double-blind experiments. Briefly /iM EDTA, 1.7 mg!ml bovine serum albumin; 10 p1 dimethylsulfoxide; 1 p1 of each primer (stock solution: 1 mM); and 3 p1 (1.5 U) of Taql polymerase (Perkin-Elmer). After five minutes of annealing at 55°C, elongation was carried out at 70°C for five a Abbreviations are: Amyl., amyloidosis; Cryo., cryoglobulinemia; Diab., diabetes; En. Ex., endo-and extra-capillary; Endoc., endocarditis; Ex. Nec., extra-capillary and necrotizing; FSG, focal and segmental glomerulosclerosis; GN, glomerulonephritis; Granul. TIN, granulomatous tubulointerstitial nephritis; Memb., membranous; Mes., mesangiocapillary; Mm., minimal; MPGN, membranoproliferative; Post-inf., postinfectious; Tub. Necr., tubular necrosis; Unci., unclassified; N.D., not done because of serum shortage.
b Following 30 cycles of amplification, PCR products were hybridized with an insert from plasmid pPR containing a 208bp sequence framed by the primers. Dot-blot hybridization was detected using this probe labeled with digoxygenin (Dot dig). [23] . The 406 bp region that we amplified is delineated by a BamHI (B) and an EcoRI (E) restriction site. These restriction sites are conserved among 60 wild CMV isolates. The probe pPR (*), delimited by two Sau3AI (S) sites, was cloned in a pGEM vector.
minutes. Samples were subsequently cycled as follows: denaturation, 10 seconds at 94°C; annealing, one minute at 55°C and elongation, one minute at 70°C.
Amplification products were transferred to nitrocellulose by dot-blotting and hybridized with a specific probe. They were also analyzed by electrophoresis in 2% agarose gels followed by ethidium bromide staining. Blots were made of the same gels according to the Suothern technique [17] . Hybridization of filters. Hybridization was performed with the gel purified plasmid pPR, a Sau3Al subfragment of the HindIII-X fragment. The probe was labeled with either alpha 32PdCTP (Southern blots) by nick translation or with digoxygenin tagged-deoxyuridine triphosphate (dig-dUTP) by random priming (pPR-dig) using a kit purchased from BoehringerMannheim (dot blots). Filters were hybridized overnight at 68°C and washed under stringent conditions in sequential baths of 2 x SSC, 0.1% SDS, then 1 x SSC, 0.1% SDS, and finally 0.1 x SSC, 0.1% SDS, as previously described [18] . Dot blots were developed according to the manufacturer's instruction, and results were scored "+" or "-" after drying of the blots. Table 1 . Arrowheads indicate hybridization with the specific 406 bp amplification product. A negative (-) and a positive (+) control were amplified in parallel.
Results and discussion although a small number of samples (patients 3, 18 and 20) gave discordant results with the two tests. By Southern blot (Fig. 2) , Detection of CMV genome in seropositive patients 8 of the 20 kidney specimens yielded a 406 bp band characterTwenty patients of this series had anti-CMV antibodies by istic of the PCR amplification product of the CMV genome. the latex agglutination assay and/or EIA (Table 1) . They in-Only 3 of them showed clear positivity by dot blot with a eluded 14 males and 6 females aged from 23 to 78 years (mean nonradioactive labeled probe. Although this technique can be age 59). The sensitivity of the latex agglutination was similar to more widely used in hospital-associated laboratories, its interthat of the enzyme immunoassay developed in our laboratory, est was limited in our hand by its lower sensitivity. It may also These results suggest that the CMV genome may persist in the kidney after serologically-proven viral infection, and most likely explain why kidneys from seropositive individuals may be a source of contamination upon grafting.
Detection of CMV genome in seronegative patients
This group was composed of nine males and one female ranging in age from 16 to 72 years (mean age 36; Table 1 ). All were negative by both serological tests. CMV DNA could be found in 3 of 10 patients (Fig. 2 ), who were positive by both dot and Southern blots, while one was only positive by dot blot. All samples of mouse kidney amplified in parallel were negative. These results confirm the high sensitivity of PCR methods.
They are in keeping with previous observations made in transplanted patients. First, in renal transplant recipients, PCR assay was shown to be the most sensitive test to detect CMV in urines when compared with enzyme-linked immunosorbent assay, DNA hybridization and direct virus isolation [121. This finding was recently confirmed by LOning et al [19] who demonstrated CMV DNA by PCR despite negativity of in situ hybridization and immunohistochemistry. Second, in bone marrow grafted patients, a prospective longitudinal study indicated that CMV DNA detection by PCR in blood was more sensitive than virus culture and CMV antibody status for the diagnosis of CMV infection [10] . Moreover, epidemiological studies have shown that seronegative subjects may be positive for CMV genome by PCR [20] . Our data further suggest that kidneys from seronegative donors may also be contaminating, although further study is required to establish correlation between PCR positivity and infectious potential.
It is interesting to note that in the two groups of patients taken as a whole, serologic and PCR data did not correlate with any type of nephropathy.
In conclusion, the present study shows the feasibility of PCR assay for the specific detection of CMV genome in kidney biopsies. This test may be a powerful tool to study in more detail the transmission of CMV infection in kidney recipients and to analyze the relationship between CMV infection and graft rejection. Furthermore, it indicates that, because of the high incidence (37%) of CMV genome in kidney biopsies, one must be very cautious when interpreting the possible relationship between its detection and the pathogenesis of certain types of glomerulonephritis recently suggested by Muller et al for IgA nephropathy [21] .
